The evolution of SARS-CoV-2

PV Markov, M Ghafari, M Beer, K Lythgoe… - Nature Reviews …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of
deaths and substantial morbidity worldwide. Intense scientific effort to understand the …

Convergent evolution in SARS-CoV-2 spike creates a variant soup from which new COVID-19 waves emerge

D Focosi, R Quiroga, S McConnell… - International journal of …, 2023 - mdpi.com
The first 2 years of the COVID-19 pandemic were mainly characterized by recurrent
mutations of SARS-CoV-2 Spike protein at residues K417, L452, E484, N501 and P681 …

COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis

JW Senefeld, M Franchini, C Mengoli… - JAMA Network …, 2023 - jamanetwork.com
Importance Patients who are immunocompromised have increased risk for morbidity and
mortality associated with coronavirus disease 2019 (COVID-19) because they less …

Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources

DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - nature.com
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75

J Huo, A Dijokaite-Guraliuc, C Liu, D Zhou, HM Ginn… - Cell reports, 2023 - cell.com
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have caused
successive global waves of infection. These variants, with multiple mutations in the spike …

Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier, SR Schulz… - The Lancet Infectious …, 2023 - thelancet.com
Vaccination represents the key strategy to control the COVID-19 pandemic through induction
of neutralising antibody responses and T cellassociated immunitythat substantially decrease …

Dengue: update on clinically relevant therapeutic strategies and vaccines

M Palanichamy Kala, AL St. John… - Current Treatment Options …, 2023 - Springer
Opinion statement Dengue viruses (DENV) continue to circulate worldwide, resulting in a
significant burden on human health. There are four antigenically distinct serotypes of DENV …

Decline of RSV-specific antibodies during the COVID-19 pandemic

G den Hartog, PB van Kasteren, RM Schepp… - The Lancet Infectious …, 2023 - thelancet.com
1 Thompson MG, Yoon SK, Naleway AL, et al. Association of mRNA vaccination with clinical
and virologic features of COVID-19 among US essential and frontline workers. JAMA 2022; …

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies

D Focosi, S McConnell, A Casadevall - Drug Resistance Updates, 2022 - Elsevier
Abstract WHO-defined SARS-CoV-2 variants of concern (VOC) drive therapeutics and
vaccine development. The Omicron VOC is dominating the arena since November 2021, but …

A critical analysis of the use of cilgavimab plus tixagevimab monoclonal antibody cocktail (Evusheld™) for COVID-19 prophylaxis and treatment

D Focosi, A Casadevall - Viruses, 2022 - mdpi.com
Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike monoclonal
antibody (mAb) cocktail designed not only for treatment but also with pre-exposure …